FIELD: chemistry.
SUBSTANCE: invention relates to compositions of active cytokine - interferone-gamma, and to cost-effective methods of obtaining the claimed compositions and of treatment and immune reaction acceleration. The methods involve introduction of alternated recombinant cell (ARC) represented by P. Fluorescens and including heterologic gene of interferone-gamma.
EFFECT: increased specific activity of interferone.
22 cl, 10 ex, 13 tbl, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMARKER FOR PATIENT'S MONITORING | 2010 |
|
RU2542435C2 |
| IMMUNOGENIC COMPOSITIONS COMPRISING SILICIFIED VIRUS AND METHODS OF USE | 2014 |
|
RU2676083C2 |
| ANTI-CANCER VACCINES TARGETING PRAME AND THEIR APPLICATIONS | 2018 |
|
RU2748903C1 |
| BORIS-TARGETED ANTI-CANCER VACCINES AND METHODS FOR APPLICATION THEREOF | 2018 |
|
RU2799786C2 |
| ANTICANCER VACCINES TARGETING BORIS AND METHODS OF THEIR APPLICATION | 2018 |
|
RU2759681C1 |
| ENHANCER OF T-CELLS OR B-CELLS WITH MEMORY FUNCTION, INHIBITOR OF CANCER RECURRENCE AND INDUCER FOR INDUCING MEMORY FUNCTION IN T-CELLS OR B-CELLS | 2018 |
|
RU2802824C2 |
| EXTENDED ADOPTIVE CELL THERAPY | 2014 |
|
RU2703438C2 |
| ANTIBODY AGAINST PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) AND APPLICATION THEREOF | 2015 |
|
RU2661678C1 |
| DETERMINATION OF DOSE FOR IMMUNOTHERAPEUTIC AGENTS | 2017 |
|
RU2771717C2 |
| METHOD FOR MALIGNANT TUMOUR DIAGNOSTICS AND DIAGNOSTIC KIT BY NK-CELLS ACTIVITY MEASUREMENT | 2012 |
|
RU2635194C2 |
